The logic of the experiment rests on a long-standing observation about how plants control their secondary metabolism. Isoflavonoids are built through a branched phenylpropanoid pathway, and the flow of metabolites through that pathway is governed by transcription factors, proteins that switch suites of biosynthetic genes on or off. Earlier work had shown that GmMYB100, an R2R3-type MYB transcription factor, acts as a negative regulator of flavonoid biosynthesis in soybean. In other words, when the gene is active, it suppresses the expression of enzymes that make isoflavones. Remove the brake, the researchers reasoned, and the pathway should run faster, accumulating more of the valuable end products in the seed.

To test that idea, the team designed a single guide RNA, the molecular address label that directs the Cas9 nuclease to a specific DNA sequence, targeting the first exon of GmMYB100. The guide RNA was cloned into the plant expression vector pHSE401, which carries the Cas9 gene along with the hptII marker used to select transformed cells. The construct was then delivered into soybean embryogenic tissue using Agrobacterium tumefaciens strain EHA105, the workhorse delivery vehicle of plant transformation. This approach is well established for soybean, a crop that has historically been more recalcitrant to genetic manipulation than rice or tomato, making each successful editing pipeline a technical achievement in its own right.

Confirming that the editing had actually worked required several layers of molecular characterization. The researchers first verified that the Cas9 and hptII genes had stably integrated into the genomes of the regenerated T0 plants, the first generation grown from edited cells. They then sequenced the target region of GmMYB100 and looked for the telltale signatures of Cas9 activity: insertion and deletion mutations, or indels, at the cut site. Because Cas9 repairs are often frameshift mutations, they typically scramble the reading frame of the gene and destroy the function of the resulting protein. Finding indels at the target site in the recovered plants confirmed that GmMYB100 had been successfully knocked out.

The payoff came when the team measured isoflavone levels in the seeds of the edited lines. Compared with non-transformed control plants, the edited T0 soybeans accumulated 2.85 times more daidzein and 1.23 times more genistein. The asymmetry between the two compounds is itself informative. Daidzein and genistein sit at related branch points of the isoflavonoid pathway, and the different magnitudes of increase suggest that releasing the GmMYB100 brake redirects metabolic flux unevenly across the network, favoring the branch leading to daidzein. Such differential responses are common in metabolic engineering and highlight why measuring individual metabolites, rather than total isoflavones alone, matters when evaluating an edited crop.

To understand how the metabolite changes arose, the researchers performed quantitative reverse-transcription PCR on immature cotyledons, mature cotyledons and whole seeds, the tissues where isoflavones accumulate during grain development. The analysis revealed significant upregulation of the major isoflavone biosynthetic genes across these tissues, consistent with the enhanced metabolite accumulation. This coherence between transcript levels and metabolite levels is important: it indicates that the phenotype is not an artifact of measurement or of stress responses to tissue culture, but a genuine rewiring of the seed’s metabolic program following loss of the repressor.

The study fits into a rapidly growing body of work using CRISPR/Cas9 not to fight disease or pests, but to upgrade the nutritional and industrial quality of crops. Similar strategies have produced high-oleic rice, elevated gamma-aminobutyric acid in rice grains, boosted beta-carotene in banana fruit, enriched lycopene in tomato, raised resistant starch in rice and increased seed oil content in rapeseed. In soybean specifically, previous efforts to raise isoflavones relied on overexpressing biosynthetic genes or transcriptional activators, or on RNA interference to silence competing pathway branches. The new work demonstrates that simply removing a negative regulator can achieve a comparable outcome with a smaller genetic footprint.

That smaller footprint matters for regulation and public acceptance. Because the edit consists of small indels in an endogenous gene, with no foreign DNA necessarily retained after segregation, lines derived from such editing can, in principle, be indistinguishable from natural variants. The researchers note that disrupting GmMYB100 relieves negative regulation of the isoflavonoid biosynthetic pathway and establishes the gene as an effective target for CRISPR/Cas9-mediated metabolic engineering. In soybean, where outcrossing is limited and transgene containment has been a practical concern, a strategy that relies on knocking out a native repressor is an attractive alternative to transgenic overexpression approaches.

The health context gives the work its broader resonance. Soy isoflavones are phytoestrogens, plant compounds that interact with estrogen receptors, and epidemiological and clinical studies have associated their consumption with improved cardiovascular risk markers, particularly in women during early menopause, as well as with antioxidant and possible anti-metastatic effects in laboratory models. Soybean is a dietary staple across much of Asia and a ubiquitous ingredient in processed foods and animal feed worldwide, so even modest increases in seed isoflavone content could translate into meaningful shifts in population-level intake. The authors also point to isoflavones’ role in plant defense, where they contribute to resistance against pathogens, suggesting the edit could carry agronomic as well as nutritional benefits.

There are, of course, steps between a T0 greenhouse plant and a farmer’s field. The edited plants in this study are the first generation after transformation, and the stability of the mutations, the consistency of the isoflavone trait across subsequent generations, and any effects on yield, seed composition or stress tolerance all remain to be characterized. The researchers were supported by the Department of Science and Technology, Government of India, through its Women Scientist-A program and its FIST infrastructure scheme. Their work, published online on 30 August 2026, adds GmMYB100 to the short but growing list of repressor genes whose removal has unlocked higher levels of health-promoting compounds in staple crops, and it offers breeders a practical, precise template for building a more nutritious soybean one targeted mutation at a time.

Subject of Research: CRISPR/Cas9 knockout of the GmMYB100 transcription factor to enhance isoflavone biosynthesis in soybean seeds

Article Title: CRISPR/Cas9-mediated targeted mutagenesis of GmMYB100 to increase isoflavone content in soybean seeds

Article References: Vidya, N., Saravanan, K., Halka, J., Kowsalya, K., Preetha, J. S. Y., Anand, M., Vaz, M. A. A., Appunu, C., Gurusaravanan, P., Dibyajyoti, P., & Arun, M. (2026). CRISPR/Cas9-mediated targeted mutagenesis of GmMYB100 to increase isoflavone content in soybean seeds. 3 Biotech, 16(9), Article 399. https://doi.org/10.1007/s13205-026-05033-1

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05033-1

Keywords: soybean, CRISPR/Cas9, GmMYB100, isoflavones, daidzein, genistein, genome editing, metabolic engineering, transcription factor, Agrobacterium tumefaciens, seed nutrition, Glycine max

The review’s foundation is biodiversity. Thailand hosts a rich array of legumes spanning the major Fabaceae subfamilies, including staple crops such as Glycine max (soybean), Vigna radiata (mung bean), Cajanus cajan (pigeon pea), Clitoria ternatea (butterfly pea) and Vigna unguiculata (cowpea). Genetic work using AFLP markers has revealed that Thailand and neighboring Myanmar constitute a center of diversity for the genus Vigna, particularly the section Angulares. The rice bean, Vigna umbellata, appears to have undergone a single domestication event in northern Thailand and adjacent Myanmar, while wild populations of black gram in the Thai north are genetically distinct from Indian cultivated lines, representing unique germplasm of considerable breeding and conservation value. This genetic wealth is not merely of academic interest; it underpins crop improvement, bioprospecting and the resilience of farming systems facing climate stress.

Ethnobotanical documentation gives this biodiversity its cultural texture. Surveys among Karen communities in northern Thailand recorded 83 leguminous species across 45 genera, used variously as food, medicine and raw material, with soybean holding a dual dietary and medicinal role and butterfly pea serving as both natural colorant and traditional remedy. A nationwide systematic review compiled 261 medicinal legume species from 98 genera, drawing on more than five thousand use reports covering some 420 disorders, and identified high-use species such as Biancaea sappan, Cassia fistula and Senna siamea as priority candidates for public herbal-medicine development. In the northeastern province of Maha Sarakham, field surveys with 260 informants documented 83 Fabaceae taxa across 52 genera, with cultivated food legumes showing the highest use values and Abrus precatorius and Albizia lebbeck recording strong consensus for treating skin ailments. Forty-four of those taxa had never before been recorded for the province, a reminder of how incomplete the national picture remains.

Beneath the ground, an invisible partnership shapes much of this success. Legumes form symbiotic relationships with nitrogen-fixing bacteria, and studies of Thai ecosystems show that native species are nodulated predominantly by Mesorhizobium, whereas introduced legumes tend to associate with Bradyrhizobium. This specificity influences which species thrive where, and it delivers an agricultural dividend: biological nitrogen fixation enriches soil, reduces dependence on synthetic fertilizers and supports microbial diversity, including associations with arbuscular mycorrhizal fungi that improve crop tolerance to drought, salinity and heat. Farmers already exploit these properties through crop rotation, intercropping and cover cropping. Research on rice bean integration into maize-based systems in northern Thailand found that legume rotation improves soil health and offers a viable alternative to monoculture, although adoption is constrained by market prices and labor demands.

The chemistry of these plants explains much of their medicinal reputation. Legumes are rich in phenolic compounds, including isoflavones such as genistein, daidzein, biochanin A and formononetin, alongside tannins, saponins, flavonoids, polysaccharides and bioactive peptides. These molecules underpin a spectrum of pharmacological activities documented in the review: antioxidant effects through free-radical scavenging, anti-inflammatory action via suppression of pro-inflammatory cytokines, antidiabetic activity through inhibition of alpha-amylase and alpha-glucosidase and through angiotensin-converting-enzyme-inhibitory peptides, antimicrobial effects that disrupt bacterial and fungal growth and biofilm formation, cardioprotective lipid-lowering and endothelial benefits, anticancer mechanisms involving cell-cycle control and apoptosis, and early indications of neuroprotection. Fermentation and germination, both traditional Thai practices, can raise concentrations of these compounds while reducing antinutritional factors such as phytates and lectins, and rhizobial inoculation has been reported to boost phenolic and flavonoid content in the plants themselves.

The authors are careful, however, to flag the limits of the evidence. Much of the phytochemical data is extrapolated from temperate perennial legumes rather than measured directly in Thai-grown material, and comprehensive species-specific profiling under local agro-climatic conditions is still lacking. Climate and elevation are known to influence phytochemical diversity, meaning Thai specimens could differ chemically from their relatives elsewhere. The review also confronts a persistent translational gap: many bioactivity findings derive from crude extracts rather than standardized fractions, doses effective in cell and animal models often exceed what is physiologically attainable in humans, and the oral bioavailability of isoflavones and phenolic peptides is limited by poor solubility and first-pass metabolism. Few registered human trials involve indigenous Thai legume varieties at all; most clinical work on legume isoflavones concerns soy preparations for menopausal and cardiometabolic endpoints.

On the industrial front, the possibilities extend well beyond the pharmacy. Extrusion cooking is already used to turn legume flours into ready-to-eat snacks, gluten-free products and meat analogues while improving digestibility and neutralizing antinutrients. Solid-state fermentation with fungi such as Pleurotus ostreatus has been shown to raise protein levels in lentils, chickpeas and soybeans while lowering phytate and tannin content, and controlled fermentation with lactic acid bacteria, Bacillus species and yeasts can generate bioactive peptides with antioxidant, antihypertensive and immunomodulatory properties. Plant-based protein demand is rising globally, and underutilized native legumes could diversify both Thai agriculture and regional food security. Encapsulation technologies, including liposomes and nanocarriers, are being developed to protect sensitive compounds and improve their absorption in functional foods and supplements.

Perhaps the most surprising frontier is materials science. Legume proteins and polysaccharides can be processed into biodegradable films and bioplastics through solvent casting, extrusion and compression molding. Studies of soybean protein isolate films, mung bean protein and starch films, and lentil flour films show respectable tensile strength and barrier properties, though water sensitivity remains a challenge. Remedies include enzymatic crosslinking with transglutaminase, blending with other biopolymers and incorporating nanomaterials, while added plant extracts can create active packaging that extends shelf life. Because these materials are compostable and derived from renewable crops, they could reduce plastic pollution and support a circular economy that converts agro-residues into value-added products, with benefits flowing back to rural communities.

The review’s authors close with a research agenda that is as pragmatic as it is ambitious. They call for systematic phytochemical profiling of Thai-grown germplasm, expanded quantitative ethnobotanical surveys across Thailand’s regions and ethnic groups, pharmacokinetic and pharmacodynamic characterization followed by adequately powered randomized controlled trials on standardized preparations, scalable processing technologies with improved delivery systems, and integrated breeding and conservation of indigenous genetic resources. Emerging tools such as genomic selection and CRISPR/Cas9 gene editing could accelerate the development of disease-resistant and climate-resilient cultivars, while phytosome and nano-delivery systems may unlock the full bioavailability of legume bioactives. The through-line of the analysis is that Thailand’s legumes are not relics of folk medicine but living resources whose value spans nutrition, therapeutics, sustainable packaging and climate-smart agriculture. Realizing that value, the authors argue, will require ethnobotanists, food scientists, pharmacologists and industry to work from the same evidence base, and to treat the traditional knowledge of communities like the Karen not as anecdote but as a starting point for rigorous, validated innovation.

Subject of Research: Ethnomedicinal uses, phytochemistry and industrial applications of Thai Fabaceae legumes

Article Title: Ethnomedicinal Uses of Thai Legumes (Fabaceae) and Their Potential in Industrial Applications

Article References: Arshad, M. T., Awlqadr, F. H., Ullah, I., Shehzadi, M., Ahmad, A., Ikram, A., Khalid, M., & Hossain, M. S. (2026). Ethnomedicinal Uses of Thai Legumes ( Fabaceae ) and Their Potential in Industrial Applications. Food Science & Nutrition, 14(10), Article e72343. https://doi.org/10.1002/fsn3.72343

Image Credits: AI Generated

DOI: 10.1002/fsn3.72343

Keywords: Thai legumes, Fabaceae, ethnomedicine, phytochemicals, isoflavones, nitrogen fixation, functional foods, plant-based protein, bioplastics, fermentation, Vigna, sustainable agriculture

Phytoestrogens are secondary metabolites that plants use for their own purposes, defending against disease and herbivores, supporting reproduction, and even coloring flowers. Chemically, they are defined by two hydroxyl groups attached to a phenolic ring, a structure close enough to 17β-estradiol that the phenolic group can bind to estrogen receptors in animals, acting as either an agonist or an antagonist. The most common forms in plants are conjugated glycosides, which are biologically inactive until gut bacteria and intestinal enzymes cleave the sugar groups, making bioavailability dependent on each species’ digestive machinery. Once absorbed, phytoestrogens are conjugated in the liver, circulate in the bloodstream, and are eventually excreted in urine.

The review organizes these compounds into two broad chemical families. Flavonoids, built on a diphenyl propane skeleton of two benzene rings closed by a heterocyclic pyran ring, include isoflavones such as genistein, daidzein, biochanin A, and formononetin; flavones such as luteolin and apigenin; and coumestans, of which coumestrol is the standout. Non-flavonoids comprise the stilbenes, including resveratrol, and the lignans, which gut metabolism converts into enterodiol and enterolactone. Coumestrol is particularly potent, showing 30 to 100 times the estrogenic activity of isoflavones because its two hydroxyl groups sit in positions matching those of estradiol, allowing it to inhibit key steroidogenic enzymes such as aromatase and 3-hydroxysteroid dehydrogenase.

Legumes are the richest sources, with many feed legumes containing phytoestrogens at 5 to 25 percent of their composition. In soybeans, genistein and daidzein together account for up to 90 percent of isoflavones, while red clover is dominated by formononetin and biochanin A. Concentrations vary with temperature, humidity, light, plant age, fertilization, and infection, and different compounds accumulate in different plant parts. Flax and sesame seeds are the most abundant lignan sources, coumestans concentrate in sprouts and fodder crops, and phytosterols such as sitosterol appear in plant oils and even in pulp mill effluents at levels with biological effects. Algae, cyanobacteria, and aquatic macrophytes may add further phytoestrogens to aquatic ecosystems, though their significance remains poorly quantified.

At the right doses, phytoestrogens can genuinely help farmed fish. Low concentrations of genistein enhanced growth in goldfish and yellow perch by modulating the growth hormone and insulin-like growth factor I axis. Their polyphenolic structure gives them antioxidant properties, scavenging free radicals and reducing oxidative stress. Moderate intake has been linked to enhanced lysozyme activity and leukocyte function, and equol, a metabolite of daidzein, promoted ovarian development and fecundity in female beluga sturgeon. Phytoestrogens can also induce vitellogenin synthesis in fish hepatocytes, hinting at potential as natural alternatives to synthetic hormones in reproductive management.

The darker side emerges when exposure is high or prolonged. As xenoestrogens, phytoestrogens bioaccumulate in fish tissues and drive reproductive abnormalities: male fish produce aberrant vitellogenin and show reduced sperm counts, while females suffer lower fecundity and egg hatchability. In rainbow trout, elevated dietary phytoestrogens impaired lipid metabolism and caused excess fat accumulation in hypertrophic adipocytes, threatening product quality. Estradiol-like signaling downregulates the GH/IGF axis in salmonids, boosting protein degradation and suppressing protein synthesis in muscle, and phytoestrogens such as genistein and daidzein slowed protein synthesis in trout muscle cells. High dietary soy isoflavones significantly reduced weight gain, feed efficiency, and whole-body lipid content in Japanese flounder. Immunity can also suffer: in beluga sturgeon, dietary phytoestrogens reduced lysozyme and IgM concentrations, echoing mammalian findings where genistein shrank the thymus in mice.

Reproductive disruption is the most dramatic effect. Genistein inhibits ovarian aromatase expression while raising serum testosterone and estradiol, yet reduced estrogen receptor expression means vitellogenin production falls, leaving female common carp with smaller, less vitellogenic ovaries. In channel catfish, chronic dietary genistein at 4 and 8 milligrams per gram produced more phenotypic males and intersex individuals, likely because the compound both mimics and blocks estrogen by inhibiting aromatase. Sperm quality is vulnerable too: genistein-enriched diets reduced sperm motility and concentration in rainbow trout in a dose-dependent manner, and in vitro genistein exposure cut sperm motility, ATP content, and fertilization rates in channel catfish and walleye. Yet the picture is not uniform. In fighting fish, waterborne genistein and β-sitosterol had no effect on sperm quality, and soy protein concentrate showed no estrogenic effect on trout juveniles.

These contradictions reflect a deeper truth the review emphasizes: responses are intensely species-specific. Carnivorous sturgeon metabolize phytoestrogens slowly, so the compounds accumulate in tissues and perturb sex differentiation, while omnivorous common carp show more moderate responses, likely thanks to metabolic adaptability. Aromatase inhibition by phytoestrogens varies across species, tissues, and developmental stages, and even within a species, individuals differ by sex, age, and genetic background in the expression of metabolic enzymes such as cytochrome P450s. The authors point to striking parallels beyond fish: Southern White Rhinoceroses show marked estrogen receptor activation on phytoestrogen exposure that their one-horned relatives do not, a difference implicated in captive breeding failures.

Fortunately, mitigation is feasible. Extensive pre-cooking before crushing removes 50 to 80 percent of the initial isoflavone content of soy products, soaking and boiling leach daidzein and genistein into water, and heating triggers Maillard-type reactions and auto-degradation that lower genistein levels. Growing soybeans at higher temperatures reduces isoflavone accumulation. Enzymatic treatments using laccases and peroxidases can degrade isoflavones and lignans into less bioavailable forms, lactic acid bacteria fermentation modifies genistein and daidzein during processing, and selective breeding is producing low-phytoestrogen soy, clover, and legume cultivars without sacrificing yield. Alternative plant proteins such as pea, lupine, and beans carry lower phytoestrogen loads.

The review closes with a regulatory warning. While the fungal mycoestrogen zearalenone has guidance values in livestock feed, ranging from 0.1 to 0.5 milligrams per kilogram under European Commission Recommendation 2006/576/EC, no such thresholds exist for naturally occurring phytoestrogens in aquafeeds, despite teleost fish being especially sensitive to hormonal perturbation during early development and gonadal differentiation. The authors call for species-specific toxicological studies, dose-response relationships, and maximum residue limits tailored to aquaculture, alongside long-term exposure research and ecological assessments of farm effluents, which can carry phytoestrogens into wild fish populations. As plant-based feeds become the backbone of sustainable aquaculture, managing these invisible hormones may prove as important as the protein itself.

Subject of Research: Effects of phytoestrogens in plant-based aquafeeds on fish growth, reproduction, and sex differentiation

Article Title: Phytoestrogens in aquaculture: friend or foe to fish growth and reproductive health?

Article References: Phytoestrogens in aquaculture: friend or foe to fish growth and reproductive health?. (n.d.). https://doi.org/10.1186/s44315-025-00037-7

Image Credits: AI Generated

DOI: 10.1186/s44315-025-00037-7

Keywords: phytoestrogens, aquaculture, aquafeed, genistein, isoflavones, endocrine disruption, fish reproduction, sex differentiation, vitellogenin, aromatase, soybean meal, fish health

The research team, led by Xinkang Feng, Daqian Sun, and senior authors Lijuan Qiu, Xiaobo Wang, and Yinghui Li, began with an unusually deep phenotyping effort. They grew 311 cultivated soybean accessions in Beijing over three consecutive growing seasons, from 2009 to 2011, and measured six distinct isoflavone components in the harvested seeds. The data revealed a clear hierarchy: glycoside-type isoflavones such as genistin, glycitin, and daidzin accumulated at far higher levels than their aglycone counterparts, with genistin alone accounting for 32.75 percent of total isoflavones while genistein made up just 4.23 percent. Statistical analysis using best linear unbiased prediction showed that glycoside-type components correlated strongly with total isoflavone content, with Pearson coefficients between 0.71 and 0.89, and that total content and genistin were substantially heritable, with broad-sense heritability estimates of 0.52 and 0.57 respectively. Aglycones, by contrast, showed heritability of only 0.12 to 0.30, suggesting they are far more sensitive to environmental conditions.

With a reliable phenotypic foundation in place, the researchers turned to a dual-pronged genetic strategy. First, a genome-wide association study scanned 4,765,428 single nucleotide polymorphisms across the panel using the FarmCPU model, with population structure controlled through principal components and significance assessed by Bonferroni correction. This analysis mapped 22 quantitative trait loci for isoflavone traits, seven of which overlapped with previously reported regions, lending confidence to the results. A particularly strong signal converged at the distal end of chromosome 5, where association signals for four different isoflavones clustered within a 74-kilobase window in a region the team designated qISO.Gm05. Second, a transcriptome-wide association study examined exon-level expression data from developing seeds at the R5.5 stage, testing 154,119 exons across 204 accessions. Among 71 significant genes, one stood out: Glyma.05G244100, repeatedly detected for four isoflavones, whose exon 2 usage correlated positively with seed isoflavone content and which sat squarely within the major qISO.Gm05 locus. The team named this convergence candidate GmISO5.

What makes GmISO5 remarkable is its identity. The gene encodes a member of the phosphatidylethanolamine-binding protein family, related to the well-known MOTHER OF FT AND TFL1, or MFT, proteins that govern flowering time, seed development, and germination in diverse plants. In soybean, this locus had previously been characterized as GmMFT, or GmST05, a major determinant of seed oil and protein content. No PEBP-family protein had ever been directly linked to isoflavone biosynthesis, making GmISO5 an unexpected addition to a regulatory repertoire previously dominated by MYB transcription factors and zinc-finger proteins. Expression analysis confirmed that GmISO5 is specifically active in developing seeds, peaking around 30 days after flowering, with the strongest signal in the cotyledon and embryonic axis rather than the seed coat.

To test whether GmISO5 truly drives isoflavone accumulation, the researchers generated two independent CRISPR/Cas9 knockout lines in the Wm82 background, which naturally carries the low-isoflavone allele. Both lines carried small frameshift deletions in exon 1 that introduced premature stop codons. The metabolic consequences were dramatic. Total seed isoflavones plummeted from 1,375.52 micrograms per gram in wild-type seeds to 273.67 micrograms per gram in the mutants, a reduction of 80.1 percent, with steep declines in glycitin, daidzin, daidzein, glycitein, and genistein. RNA sequencing of developing seeds revealed thousands of differentially expressed genes, and strikingly, 30 of the 65 known isoflavone biosynthetic genes were among those regulated by GmISO5, indicating that this single protein exerts broad transcriptional control over the entire pathway network rather than tweaking a single step.

Molecular dissection pinpointed two direct targets. GmCHS1 encodes chalcone synthase, the enzyme that catalyzes an early, committed step in flavonoid and isoflavonoid production, while GmHIDH encodes 2-hydroxyisoflavanone dehydratase, which operates in the isoflavone-specific branch to produce the aglycones daidzein and genistein. Yeast one-hybrid assays showed that GmISO5 associates with both promoters, and dual-luciferase reporter assays in tobacco leaves demonstrated that the protein transactivates them, producing markedly stronger luminescence signals than controls. Electrophoretic mobility shift assays then confirmed direct, sequence-specific binding: recombinant GmISO5 bound two fragments of the GmHIDH promoter and one fragment of the GmCHS1 promoter, with binding competed away by excess unlabeled probe and abolished by mutations. The three bound fragments shared a distinctive A/T-rich arrangement, TTAAAA separated by four to six nucleotides from ATAAT, which the authors propose may contribute to promoter recognition, though further work is needed to confirm it as a general binding motif.

Population genetics added an evolutionary twist. Analyzing sequence variation in 1,566 re-sequenced soybean accessions, the team found that GmISO5 variants fall into two major haplotypes: GmISO5-High, associated with elevated isoflavone accumulation, and GmISO5-Low, associated with reduced levels. The frequency of the low-isoflavone haplotype rose sharply from wild soybean through landraces to improved cultivars, reaching 91 percent in modern varieties. Nucleotide diversity in the surrounding 400-kilobase region declined progressively from wild soybeans to cultivars, Tajima’s D dropped in improved material, and fixation index values rose between populations, all signatures of a selective sweep. Intriguingly, accessions carrying the low haplotype also had significantly higher 100-seed weight and seed oil content, suggesting that breeders selecting for larger, oilier seeds inadvertently dragged the low-isoflavone allele along, depleting the high-isoflavone haplotype as a correlated consequence rather than by design.

Co-expression network analysis using independent component analysis reinforced the picture. Among 58 modules, one, designated IC37, showed the strongest association with isoflavone content and contained GmISO5 alongside its validated target GmHIDH and core pathway genes including CHS1, CHS11, CHR, CHI, 4CL, UGT72B8, and TT2. Subdividing IC37 revealed that Submodule 2, specifically enriched for flavonoid and isoflavonoid biosynthesis, correlated most strongly with seed isoflavone levels, marking it as the functional core of the network. The authors caution that co-expression evidence is correlative and that the module should be treated as a prioritization tool for future candidate-gene validation rather than proof of regulatory relationships.

The study’s most provocative finding concerns viral disease. Because isoflavones have been implicated in plant-pathogen interactions, and because multiplex CRISPR editing of flavonoid pathway genes has previously been shown to increase both isoflavone content and resistance to soybean mosaic virus, the team inoculated wild-type and GmISO5 knockout plants with SMV. Transcript levels of GmISO5 and GmHIDH rose in wild-type leaves two days after inoculation, but the knockout lines developed more severe symptoms and accumulated significantly more virus, as quantified by DAS-ELISA, with leaf isoflavone levels correspondingly reduced. The result implicates GmISO5 in the soybean response to SMV infection, yet the authors are careful to note that the experiments do not establish causation: reduced isoflavones may not be the direct cause of heightened susceptibility, and other GmISO5-regulated defense pathways could contribute. Genetic complementation, overexpression lines, and metabolite-rescue experiments will be needed to resolve the mechanism.

Taken together, the findings expand the known regulatory architecture of soybean isoflavone biosynthesis into an entirely new protein family and demonstrate the power of integrating genome-wide and transcriptome-wide association studies with network analysis and genome editing. For breeders, the rarity of the GmISO5-High haplotype in major production regions of the United States and northern China highlights an underutilized genetic resource for boosting the nutritional quality of soybean seeds, though any deployment must reckon with the allele’s links to seed size and oil traits that breeders have long favored. For plant virologists, the connection between a metabolic regulator and SMV susceptibility opens a fresh line of inquiry into how specialized metabolism shapes antiviral defense, one that the authors themselves flag as the study’s most important open question.

Subject of Research: Genetic regulation of seed isoflavone biosynthesis and soybean mosaic virus response in soybean

Article Title: Multi-omics integration identifies GmISO5 as a key regulator of seed isoflavone biosynthesis and implicates it in the response to soybean mosaic virus

Article References: Feng, X., Sun, D., Liu, H., Chu, L., Li, J., Li, D., Zhang, H., Wang, X., Ge, T., Zheng, H., Guo, S., Zhao, X., Li, J., Zhao, T., Li, Y., Wang, X., & Qiu, L. (2026). Multi-omics integration identifies GmISO5 as a key regulator of seed isoflavone biosynthesis and implicates it in the response to soybean mosaic virus. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2026.09.011

Image Credits: AI Generated

DOI: 10.1016/j.jare.2026.09.011

Keywords: soybean, isoflavones, GmISO5, GWAS, TWAS, CRISPR, soybean mosaic virus, PEBP family, selective sweep, seed quality, chalcone synthase, plant virology

Flavonoids are polyphenolic compounds built on a C6-C3-C6 carbon skeleton, subdivided into subclasses such as flavones, flavonols, flavanones, flavanols, isoflavones and anthocyanins depending on the arrangement of rings and chemical substituents. Each subclass occupies a distinct niche in the food supply. Citrus fruits deliver flavanones like naringin and naringenin; apples, plums and cherries supply flavanols; berries, red cabbage and eggplant are dense with anthocyanins; onions, broccoli and kale provide flavonols such as quercetin and kaempferol; and soybeans and chickpeas are the principal dietary sources of isoflavones like genistein and daidzein. Tea, coffee, cocoa and red wine contribute further to daily intake, while herbs and traditional medicinal plants such as Eucommia ulmoides and hawthorn concentrate these molecules to remarkable levels.

The biological activities of these compounds read like a checklist of PCOS pathology. Flavonoids scavenge reactive oxygen species, dampen inflammatory signaling, regulate glucose and lipid metabolism and improve insulin sensitivity. In experimental models, two molecules in particular have drawn attention. Luteolin normalized the estrous cycle and ovarian morphology in animal studies while restoring activity of the Nrf2 antioxidant pathway and its downstream genes. Quercetin regulated the ratio of luteinizing hormone to follicle-stimulating hormone, adjusted estrogen levels and reduced cholesterol, acting on the pituitary-ovarian axis in ways the authors suggest could one day translate to human therapy.

The molecular logic is intricate. Hyperandrogenism, the excess of male hormones that drives many PCOS symptoms, depends on enzymes such as CYP17A1 in ovarian theca cells. Quercetin’s ortho-dihydroxyl groups allow it to bind PI3K proteins and reduce CYP17A1 expression, curbing the conversion of progesterone to androgens. Soy isoflavones suppress testosterone production by inhibiting 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase in ovarian interstitial cells. Other flavonoids boost aromatase activity in granulosa cells, improving the conversion of androgens to estradiol and helping rebalance the LH/FSH ratio that governs ovulation.

On the metabolic front, flavonoids confront the insulin resistance that afflicts many women with PCOS and feeds a vicious cycle with hyperandrogenism. Quercetin activates the AMPKα subunit in fat cells and promotes the translocation of the GLUT4 glucose transporter to the cell membrane, enhancing glucose uptake. Flavonoids also block NF-κB and MAPK inflammatory cascades, lowering production of tumor necrosis factor-α and interleukin-6, and they induce antioxidant enzymes such as superoxide dismutase and glutathione peroxidase through the Nrf2 transcription factor. In animal models, these effects reduced cystic follicles, increased mature follicles and improved ovulation and conception rates, while protecting oocyte membranes and mitochondria from oxidative damage.

There is, however, a formidable catch: bioavailability. Most flavonoids are poorly absorbed, extensively modified by gut bacteria and liver enzymes, and rapidly excreted. Urinary excretion studies show that only 2.5 to 40 percent of dietary kaempferol and quercetin is recovered. The clinical trials that have shown promise typically used high-dose extracts of several hundred milligrams per day, whereas Western diets deliver an average of just 20 to 50 milligrams daily. This dose gap, the review argues, is the central contradiction in translating flavonoid science to the public: the question is not whether these compounds work, but how to achieve effective exposure through food.

Food engineering offers partial answers. Microencapsulation wraps flavonoid extracts in protective matrices like maltodextrin or whey protein, shielding them from light, oxygen, heat and stomach acid until they reach the intestine. Nano-encapsulation, using particles smaller than 200 nanometers such as nanostructured lipid carriers and nanoemulsions, exploits intercellular transport pathways in the gut lining; quercetin delivered this way achieved a 3.2-fold increase in oral bioavailability in animal studies. Liposomal carriers form mixed micelles that improve dispersion of fat-soluble aglycones, while enzymatic hydrolysis with β-glucosidase and fermentation with lactic acid bacteria strip sugar groups from flavonoid glycosides, converting them into more absorbable forms. Fermented soy milk and Pu’er tea are cited as successful commercial examples of this principle. Even simple food pairings help: black pepper’s piperine inhibits UGT enzymes and reduces first-pass metabolism, and modest amounts of dietary fat promote micellization of fat-soluble flavonoids.

Sensory and stability challenges remain significant engineering hurdles. Anthocyanins fade rapidly at neutral or alkaline pH, flavanols succumb to enzymatic oxidation, and flavonoids generally impart bitterness and astringency that can sink consumer acceptance. The review describes countermeasures ranging from acidified formulations and blanching to cyclodextrin inclusion and flavor masking with sweeteners like vanillin. It also sketches practical daily menus for women with PCOS: soy milk with blueberries at breakfast, onion salad with broccoli at lunch, green tea in place of afternoon coffee, and citrus fruit after dinner, with olive oil or nuts paired to boost absorption and a pinch of black pepper to extend systemic exposure.

Perhaps the most forward-looking section addresses personalization. PCOS is not one disease but a spectrum of metabolic phenotypes, and the authors propose matching flavonoid formulas accordingly: quercetin and EGCG for insulin-resistant patients, soy isoflavones for those with prominent hyperandrogenism, and anthocyanins or hawthorn leaf flavonoids for inflammation-dominant cases. Genetic polymorphisms in UGT, COMT and CYP450 enzymes, along with individual gut microbiome composition, could eventually predict who responds best to which compounds, supported by artificial intelligence screening of synergistic combinations and multi-omics mapping of flavonoid targets.

The authors are careful to note the limits of current evidence. Most clinical trials to date have been small, short, single-center studies delivering flavonoids as capsules rather than foods, and the 2023 international PCOS guidelines still stop short of recommending specific dietary patterns or micronutrient supplementation. Rigorous, multicenter, long-duration trials with standardized dietary background controls and adherence tracking are needed before flavonoid-enriched functional foods can earn regulatory approval or health claims. Yet the framework laid out — from biochemical mechanism through food processing technology to phenotype-matched dietary plans — represents an unusually complete translational roadmap. If it succeeds, the management of one of the most common endocrine disorders in women may begin not in the clinic, but in the grocery aisle.

Subject of Research: Plant flavonoids as dietary interventions for polycystic ovary syndrome

Article Title: Plant Flavonoid—Enriched Functional Foods for Polycystic Ovary Syndrome: Dietary Sources, Bioavailability Enhancement, and Personalized Intervention Strategies

Article References: Wang, J., Zhu, H., Shen, Q., Zhong, Y., Du, Y., Yu, W., Mao, F., Yao, Z., Zhu, W., Sun, L., Lin, Q., Xu, X., & Zhu, J. (2026). Plant Flavonoid—Enriched Functional Foods for Polycystic Ovary Syndrome: Dietary Sources, Bioavailability Enhancement, and Personalized Intervention Strategies. Food Science & Nutrition, 14(9), Article e72350. https://doi.org/10.1002/fsn3.72350

Image Credits: AI Generated

DOI: 10.1002/fsn3.72350

Keywords: PCOS, flavonoids, functional foods, quercetin, isoflavones, bioavailability, insulin resistance, hyperandrogenism, nanoencapsulation, personalized nutrition, polyphenols, ovarian health